Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Feasibility of multifrequency MR elastography of the seminal vesicles in healthy men, benign prostatic hyperplasia, and prostate cancer.

European radiology experimental·2026
Same authorSame journal

Loeffler's Endomyocarditis: Clinical characteristics and outcomes from a tertiary care centre registry.

International journal of cardiology·2026
Same author

Computed tomography reveals multiple origins of extreme caudal vertebral pneumaticity in sauropod dinosaurs.

Journal of anatomy·2026
Same author

Correction: Feasibility of multifrequency MR elastography of the seminal vesicles in healthy men, benign prostatic hyperplasia, and prostate cancer.

European radiology experimental·2026
Same author

Imaging-based clinical decision tree enables risk stratification of extraprostatic extension before radical prostatectomy in prostate cancer patients.

Insights into imaging·2026
Same author

Synthetically trained convolutional neural networks for time-resolved aortic segmentation of four-dimensional flow magnetic resonance imaging.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2026

Related Experiment Videos

Statin-associated focal myositis.

Patrick Asbach, Ingo Paetsch, Philipp Stawowy

    International Journal of Cardiology
    |December 25, 2007
    PubMed
    Summary

    Statin therapy can rarely cause focal myositis, a muscle inflammation. This case highlights statin-induced hip myositis, often mistaken for orthopedic issues, emphasizing the need for clinical awareness.

    Area of Science:

    • Neurology
    • Rheumatology
    • Pharmacology

    Background:

    • Statin medications are widely prescribed for cholesterol management.
    • Myositis, or muscle inflammation, is a known infrequent side effect of statin use.
    • Typical presentation involves diffuse muscle pain and weakness affecting multiple muscle groups.

    Observation:

    • A case study involving a patient presenting with isolated hip pain and symptoms mimicking orthopedic disease.
    • Initial diagnostic suspicion pointed towards an orthopedic condition due to the localized nature of the symptoms.
    • Magnetic resonance imaging (MRI) was utilized for detailed assessment of the hip musculature.

    Findings:

    • The patient was diagnosed with focal myositis, specifically affecting a hip muscle.

    Related Experiment Videos

  • The condition was ultimately attributed to the patient's statin therapy.
  • This contrasts with the more common diffuse presentation of statin-induced myositis.

    • Implications:

    • Highlights a rare but significant cause of musculoskeletal symptoms, particularly hip pain.
    • Clinicians should consider statin-induced myositis in patients presenting with orthopedic complaints, especially those on statin medication.
    • Increased awareness can lead to earlier diagnosis and appropriate management, preventing misdiagnosis and delayed treatment.